Rifampicin-Monoresistant Tuberculosis Is Not the Same as Multidrug-Resistant Tuberculosis: a Descriptive Study from Khayelitsha, South Africa

Rifampin monoresistance (RMR; rifampin resistance and isoniazid susceptibility) accounts for 38% of all rifampin-resistant tuberculosis (RR-TB) in South Africa and is increasing. We aimed to compare RMR-TB with multidrug-resistant TB (MDR-TB) in a setting with high TB, RR-TB, and HIV burdens. Patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Salaam-Dreyer, Zubeida, Streicher, Elizabeth M., Sirgel, Frederick A., Menardo, Fabrizio, Borrell, Sonia, Reinhard, Miriam, Doetsch, Anna, Cudahy, Patrick G. T., Mohr-Holland, Erika, Daniels, Johnny, Dippenaar, Anzaan, Nicol, Mark P., Gagneux, Sebastien, Warren, Robin M., Cox, Helen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Epidemiology and Surveillance
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522772/
https://www.ncbi.nlm.nih.gov/pubmed/34460307
http://dx.doi.org/10.1128/AAC.00364-21

Ejemplares similares

Ejemplares similares